Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.55
Delayed Data
As of 3:59pm ET
 +0.13 / +1.38%
Today’s Change
6.96
Today|||52-Week Range
19.63
-44.89%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Torley Helen I
President & Chief Executive Officer
Sale12/31/201516,436$17.33$284.8K-45.64%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201611,686$15.77$184.3K-40.27%
Kelley Kenneth J
Director
Buy8/28/201510,000$10.37$103.7K-48.83%
Falberg Kathryn E
Director
Buy1/13/201610,000$10.37$103.7K-6.36%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Sale12/31/20155,655$17.33$98.0K-45.64%
Torley Helen I
President & Chief Executive Officer
Sale2/06/201611,743$7.90$92.8K+28.69%
Torley Helen I
President & Chief Executive Officer
Sale6/30/20167,044$8.63$60.8K+9.15%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Sale1/05/20163,257$16.39$53.4K-42.53%
Matsui Connie L
Director
Buy9/14/201510,000$4.94$49.4K-47.32%
Falberg Kathryn E
Director
Buy1/13/201610,000$4.94$49.4K-6.36%
Page of 3